NCT00018564已完成3 期
Novel Therapies for Essential Tremor
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.
详细描述
Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Physiology, Imaging and Modeling of Essential TremorEssential TremorDystoniaParkinson DiseaseNCT03811405University of Florida12
已完成
2 期
A Pilot Efficacy and Safety Study of ST101 in Essential TremorEssential TremorNCT01332695Sonexa Therapeutics, Inc.25
终止
不适用
Transcranial Stimulation for Essential TremorEssential TremorNCT03025529Beth Israel Deaconess Medical Center8
撤回
2 期
Acamprosate and Methazolamide for Essential TremorEssential TremorNCT06312800Henry Ford Health System
已完成
2 期
A Safety/Efficacy Trial of Zonisamide for Essential TremorEssential TremorNCT00223743VA Greater Los Angeles Healthcare System25